Frédéric Collet
Direktor/Vorstandsmitglied bei ADVANCED ACCELERATOR APPLICATION SA(ADR)
Aktive Positionen von Frédéric Collet
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Vorsitzender | - | - |
Novartis Groupe France SA
 Novartis Groupe France SA Financial ConglomeratesFinance Novartis Groupe France SA is a pharmaceutical company. It provides cure for diseases. The company is headquartered in Rueil-Malmaison, France. | Vorstandsvorsitzender | 30.03.2017 | - |
| Vorsitzender | 10.03.2018 | - | |
Eurazeo Capital
 Eurazeo Capital Investment ManagersFinance Eurazeo Capital is the private equity arm of Eurazeo SA (XP: RF) in France. The firm was created in 2001 by the merger of Eurafrance and Azeo, formerly known as Gaz et Eaux. Eurazeo Capital is headquartered in Paris. Firm's customers include institutional and retail investors. | Berater | 01.03.2023 | - |
Karriereverlauf von Frédéric Collet
Statistik
International
| Frankreich | 5 |
Operativ
| Chairman | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
Novartis Pharma SAS
Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Health Technology |
Novartis Groupe France SA
Novartis Groupe France SA Financial ConglomeratesFinance Novartis Groupe France SA is a pharmaceutical company. It provides cure for diseases. The company is headquartered in Rueil-Malmaison, France. | Finance |
Eurazeo Capital
Eurazeo Capital Investment ManagersFinance Eurazeo Capital is the private equity arm of Eurazeo SA (XP: RF) in France. The firm was created in 2001 by the merger of Eurafrance and Azeo, formerly known as Gaz et Eaux. Eurazeo Capital is headquartered in Paris. Firm's customers include institutional and retail investors. | Finance |
- Börse
- Insiders
- Frédéric Collet
- Erfahrung
